Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125275511 | 12527551 | 1 | I | 20130228 | 20160622 | 20160705 | 20160705 | EXP | BR-ROCHE-1784134 | ROCHE | 42.00 | YR | F | Y | 0.00000 | 20160705 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125275511 | 12527551 | 1 | PS | Trastuzumab Emtansine | ADO-TRASTUZUMAB EMTANSINE | 1 | Unknown | U | 125427 | ||||||||||
| 125275511 | 12527551 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Unknown | U | 103792 | ||||||||||
| 125275511 | 12527551 | 3 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | ||||||||||
| 125275511 | 12527551 | 4 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | WEEKLY | U | 0 | |||||||||
| 125275511 | 12527551 | 5 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Unknown | U | 0 | ||||||||||
| 125275511 | 12527551 | 6 | SS | ANASTROZOL | ANASTROZOLE | 1 | Unknown | U | 0 | ||||||||||
| 125275511 | 12527551 | 7 | SS | LAPATINIB | LAPATINIB | 1 | Unknown | U | 0 | ||||||||||
| 125275511 | 12527551 | 8 | SS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125275511 | 12527551 | 1 | Product used for unknown indication |
| 125275511 | 12527551 | 2 | Breast cancer |
| 125275511 | 12527551 | 3 | Product used for unknown indication |
| 125275511 | 12527551 | 4 | Breast cancer |
| 125275511 | 12527551 | 5 | Product used for unknown indication |
| 125275511 | 12527551 | 6 | Product used for unknown indication |
| 125275511 | 12527551 | 7 | Product used for unknown indication |
| 125275511 | 12527551 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125275511 | 12527551 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125275511 | 12527551 | Aortic arteriosclerosis | |
| 125275511 | 12527551 | Headache | |
| 125275511 | 12527551 | Hypertension | |
| 125275511 | 12527551 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125275511 | 12527551 | 1 | 20140526 | 0 | ||
| 125275511 | 12527551 | 2 | 20110920 | 0 | ||
| 125275511 | 12527551 | 4 | 20110920 | 0 | ||
| 125275511 | 12527551 | 6 | 20120402 | 0 |